Colchicine 0.6 MG Oral Capsule — RxCUI 1550940
RxNorm drug concept · Semantic clinical drug
RxCUI 1550940
Semantic clinical drug · SCD
● Current RxNorm concept 13 FDA products
33 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1550940
Official nameColchicine 0.6 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped13
Package NDCs mapped33
Reported Medicaid activity (SDUD)9,549 prescriptions · 26 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Colchicine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It depends on the product. Most colchicine products — tablets, capsules, and the liquid Gloperba — are used to prevent gout flares in adults. Colcrys tablets and generic colchicine...
- Diarrhea is the most common side effect and it's a real nuisance for many people. Colchicine affects the lining of the gut, and nausea, cramping, and loose stools often come with i...
- Why does colchicine cause so much diarrhea?
- This is one of the most important questions you can ask. Colchicine has some serious drug interactions that have caused deaths — not just discomfort. Certain antibiotics (like clar...
🕸️ Concept Web — How Colchicine 0.6 MG Oral Capsule Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Colchicine 0.6 MG Oral Capsule
RxCUI 1550940 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Colchicine
2683IN
-
Colchicine
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Mitigare
1550941BN
-
Mitigare
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Colchicine Oral Capsule
1550939SCDF -
Colchicine Oral Product
1155484SCDG -
Colchicine Pill
1155485SCDG -
Colchicine Oral Capsule [Mitigare]
1550943SBDF -
Mitigare Oral Product
1550944SBDG -
Mitigare Pill
1550945SBDG -
Oral Capsule
316965DF -
Oral Product
1151131DFG - +1 more in this family
-
Colchicine Oral Capsule
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Colchicine 0.6 MG
315714SCDC -
Colchicine 0.6 MG Oral Capsule [Mitigare]
1550946SBD -
Colchicine 0.6 MG [Mitigare]
1550942SBDC
-
Colchicine 0.6 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Colchicine 0.6 MG
SCDC · 315714 -
Colchicine Oral Capsule
SCDF · 1550939 -
Colchicine Oral Product
SCDG · 1155484 -
Colchicine Pill
SCDG · 1155485
Brand-Name Concepts
-
Colchicine 0.6 MG Oral Capsule [Mitigare]
SBD · 1550946 -
Colchicine 0.6 MG [Mitigare]
SBDC · 1550942 -
Colchicine Oral Capsule [Mitigare]
SBDF · 1550943 -
Mitigare Oral Product
SBDG · 1550944 -
Mitigare Pill
SBDG · 1550945 -
Mitigare
BN · 1550941
📦 FDA Products & Package NDCs
13 products · 33 package NDCs
33 package NDCs map to RxCUI 1550940 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00143-3018-01 | 100 CAPSULE in 1 BOTTLE, PLASTIC (0143-3018-01) | Colchicine | Hikma Pharmaceuticals USA Inc. | 2014-10-01 |
| 00143-3018-10 | 1000 CAPSULE in 1 BOTTLE, PLASTIC (0143-3018-10) | Colchicine | Hikma Pharmaceuticals USA Inc. | 2014-10-01 |
| 00143-3018-30 | 30 CAPSULE in 1 BOTTLE, PLASTIC (0143-3018-30) | Colchicine | Hikma Pharmaceuticals USA Inc. | 2018-07-23 |
| 00254-0460-01 | 100 CAPSULE in 1 BOTTLE (0254-0460-01) | Colchicine | Par Health USA, LLC | 2023-11-01 |
| 00904-6732-04 | 30 BLISTER PACK in 1 CARTON (0904-6732-04) / 1 CAPSULE in 1... | Colchicine | Major Pharmaceuticals | 2014-10-01 |
| 31722-0099-01 | 100 CAPSULE in 1 BOTTLE (31722-099-01) | COLCHICINE | Camber Pharmaceuticals, Inc. | 2024-04-29 |
| 31722-0099-10 | 1000 CAPSULE in 1 BOTTLE (31722-099-10) | COLCHICINE | Camber Pharmaceuticals, Inc. | 2024-04-29 |
| 31722-0099-30 | 30 CAPSULE in 1 BOTTLE (31722-099-30) | COLCHICINE | Camber Pharmaceuticals, Inc. | 2024-04-29 |
| 42571-0341-01 | 100 CAPSULE in 1 BOTTLE (42571-341-01) | Colchicine | Micro Labs Limited | 2026-02-18 |
| 42571-0341-10 | 1000 CAPSULE in 1 BOTTLE (42571-341-10) | Colchicine | Micro Labs Limited | 2026-02-18 |
| 42571-0341-30 | 30 CAPSULE in 1 BOTTLE (42571-341-30) | Colchicine | Micro Labs Limited | 2026-02-18 |
| 50090-3465-00 | 4 CAPSULE in 1 BOTTLE (50090-3465-0) | Colchicine | A-S Medication Solutions | 2018-05-30 |
| 50090-3465-01 | 90 CAPSULE in 1 BOTTLE (50090-3465-1) | Colchicine | A-S Medication Solutions | 2018-06-12 |
| 59467-0318-01 | 100 CAPSULE in 1 BOTTLE (59467-318-01) | MITIGARE | Hikma Specialty USA Inc. | 2014-10-01 |
| 59467-0318-10 | 1000 CAPSULE in 1 BOTTLE (59467-318-10) | MITIGARE | Hikma Specialty USA Inc. | 2014-10-01 |
| 59467-0318-30 | 30 CAPSULE in 1 BOTTLE (59467-318-30) | MITIGARE | Hikma Specialty USA Inc. | 2018-07-26 |
| 59651-0446-01 | 100 CAPSULE in 1 BOTTLE (59651-446-01) | Colchicine | Aurobindo Pharma Limited | 2024-04-29 |
| 59651-0446-30 | 30 CAPSULE in 1 BOTTLE (59651-446-30) | Colchicine | Aurobindo Pharma Limited | 2024-07-01 |
| 59651-0446-99 | 1000 CAPSULE in 1 BOTTLE (59651-446-99) | Colchicine | Aurobindo Pharma Limited | 2024-04-29 |
| 60687-0358-25 | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-358-25) / 1 CAPS... | Colchicine | American Health Packaging | 2018-04-04 |
| 67046-0889-03 | 30 CAPSULE in 1 BLISTER PACK (67046-0889-3) | Colchicine | Coupler LLC | 2025-01-27 |
| 67046-1634-03 | 30 CAPSULE in 1 BLISTER PACK (67046-1634-3) | COLCHICINE | Coupler LLC | 2025-12-30 |
| 70010-0001-01 | 100 CAPSULE in 1 BOTTLE (70010-001-01) | Colchicine | Granules Pharmaceutical Inc. | 2024-04-29 |
| 70010-0001-03 | 30 CAPSULE in 1 BOTTLE (70010-001-03) | Colchicine | Granules Pharmaceutical Inc. | 2024-08-22 |
| 70010-0001-10 | 1000 CAPSULE in 1 BOTTLE (70010-001-10) | Colchicine | Granules Pharmaceutical Inc. | 2024-04-29 |
| 71335-2703-01 | 30 CAPSULE in 1 BOTTLE (71335-2703-1) | Colchicine | Bryant Ranch Prepack | 2025-09-26 |
| 71335-2703-02 | 10 CAPSULE in 1 BOTTLE (71335-2703-2) | Colchicine | Bryant Ranch Prepack | 2025-09-26 |
| 71335-2703-03 | 8 CAPSULE in 1 BOTTLE (71335-2703-3) | Colchicine | Bryant Ranch Prepack | 2025-09-26 |
| 71335-2703-04 | 90 CAPSULE in 1 BOTTLE (71335-2703-4) | Colchicine | Bryant Ranch Prepack | 2025-09-26 |
| 71335-2703-05 | 60 CAPSULE in 1 BOTTLE (71335-2703-5) | Colchicine | Bryant Ranch Prepack | 2025-09-26 |
| 71335-2703-06 | 3 CAPSULE in 1 BOTTLE (71335-2703-6) | Colchicine | Bryant Ranch Prepack | 2025-09-26 |
| 71335-2703-07 | 20 CAPSULE in 1 BOTTLE (71335-2703-7) | Colchicine | Bryant Ranch Prepack | 2025-09-26 |
| 71335-2703-08 | 6 CAPSULE in 1 BOTTLE (71335-2703-8) | Colchicine | Bryant Ranch Prepack | 2025-09-26 |
Observed labelers:
Bryant Ranch Prepack (8) ·
Aurobindo Pharma Limited (3) ·
Camber Pharmaceuticals, Inc. (3) ·
Granules Pharmaceutical Inc. (3) ·
Hikma Pharmaceuticals USA Inc. (3) ·
Hikma Specialty USA Inc. (3)
· +6 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
💲 Pricing (NADAC)
NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$1.9555
Range $1.9555–$6.0351
· middle 50% $1.9555–$1.9555
· 16 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.